The consistent prognostic relevance of MMP-2 is underlined by Figure 2B, in which the old group of patients (n=50) and the more recent patients group (n=31) are independently subdivided based on a low or high MMP-2 antigen content of the carcinoma, using the same cutoff value. Here, MMP2 is linked to carcinoma.